Outcome Of Abigail Alliance Case May Be Moot Due To Marketplace Issues
Executive Summary
Regardless of whether a federal appeals court determines that patients have a fundamental right to experimental therapy, it appears a host of potential problems in the marketplace will stymie increased access to such therapies in practice